Combination Therapy with Monoamine Oxidase Inhibitors and Other Antidepressants or Stimulants: Strategies for the Management of Treatment-Resistant Depression

Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study

(2015) Kara M. Smith et al.   JAMA Neurology

Severe Hypertension Related to Caffeinated Coffee and Tranylcypromine: A Case Report

(2014) Niels van der Hoeven et al.   ANNALS OF INTERNAL MEDICINE

Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)

(2014) Michel Panisset et al.   PHARMACOTHERAPY

Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression

(2013) Kenneth I. Shulman et al.   CNS DRUGS

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

(2013) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

Practical guide for prescribing MAOIs: debunking myths and removing barriers

(2012) Meghan M. Grady et al.   CNS SPECTRUMS

Tranylcypromine and Bupropion Combination Therapy in Treatment-Resistant Major Depression

(2012) Arnim Quante et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression

(2011) Daniel Souery et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Serotonin Syndrome: A Case of Fatal SSRI/MAOI Interaction

(2010) Norm Keltner   PERSPECTIVES IN PSYCHIATRIC CARE